AMGEN INC Operating Income Loss

• AMGEN INC showed an increase of +25.1% in Operating Income Loss from 2024 to 2025.
• This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $1.52 billion | Q3 2010: $1.48 billion | Q1 2011: $1.29 billion | Q2 2011: $1.33 billion | Q3 2011: $525.00 million | Q1 2012: $1.48 billion | Q2 2012: $1.59 billion | Q3 2012: $1.42 billion | Q1 2013: $1.44 billion | Q2 2013: $1.55 billion | Q3 2013: $1.69 billion | Q1 2014: $1.36 billion | Q2 2014: $1.90 billion | Q3 2014: $1.47 billion | Q1 2015: $2.02 billion | Q2 2015: $2.08 billion | Q3 2015: $2.34 billion | Q1 2016: $2.40 billion | Q2 2016: $2.38 billion | Q3 2016: $2.53 billion | Q1 2017: $2.59 billion | Q2 2017: $2.70 billion | Q3 2017: $2.44 billion | Q1 2018: $2.73 billion | Q2 2018: $2.83 billion | Q3 2018: $2.32 billion | Q1 2019: $2.47 billion | Q2 2019: $2.68 billion | Q3 2019: $2.48 billion | Q1 2020: $2.36 billion | Q2 2020: $2.32 billion | Q3 2020: $2.45 billion | Q1 2021: $2.13 billion | Q2 2021: $828.00 million | Q3 2021: $2.38 billion | Q1 2022: $2.50 billion | Q2 2022: $2.18 billion | Q3 2022: $2.66 billion | Q1 2023: $1.92 billion | Q2 2023: $2.68 billion | Q3 2023: $2.02 billion | Q1 2024: $991.00 million | Q2 2024: $1.91 billion | Q3 2024: $2.05 billion | Q1 2025: $1.18 billion | Q2 2025: $2.66 billion | Q3 2025: $2.53 billion.
• Over the full 18 years of available data (2008 to 2025), AMGEN INC's Operating Income Loss has grown by 74.1%.
• Historical annual values: Fiscal year 2025: $9.08 billion | Fiscal year 2024: $7.26 billion | Fiscal year 2023: $7.90 billion | Fiscal year 2022: $9.57 billion | Fiscal year 2021: $7.64 billion | Fiscal year 2020: $9.14 billion | Fiscal year 2019: $9.67 billion | Fiscal year 2018: $10.26 billion | Fiscal year 2017: $9.97 billion | Fiscal year 2016: $9.79 billion | Fiscal year 2015: $8.47 billion | Fiscal year 2014: $6.19 billion | Fiscal year 2013: $5.87 billion | Fiscal year 2012: $5.58 billion | Fiscal year 2011: $4.31 billion | Fiscal year 2010: $5.55 billion | Fiscal year 2009: $5.51 billion | Fiscal year 2008: $5.21 billion.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026